key: cord-1011344-zwy5deyn
authors: Bhardwaj, Abhishek; Kirincich, Jason; Rampersad, Penelope; Soltesz, Edward; Krishnan, Sudhir
title: Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
date: 2022-04-25
journal: Resuscitation
DOI: 10.1016/j.resuscitation.2022.04.021
sha: 2fbecb12b18847dc91a99875893b3b5a46888254
doc_id: 1011344
cord_uid: zwy5deyn

nan

Since the beginning of the COVID-19 pandemic, fulminant myocarditis (FM) has been recognized as one of the cardiac complications of COVID-19 disease caused by SARS-CoV-2 virus. FM is characterized by life threatening heart failure and cardiogenic shock, and often requires mechanical circulatory support (MCS). While recently there has been a significant interest regarding the rare incidence of COVID-19 vaccine related myocarditis, there is limited data on management of FM associated with COVID19 disease with veno-arterial extracorporeal membrane oxygenation (VA-ECMO). We report a case series of nine patients with COVID-19 disease associated FM who were managed with VA-ECMO at the Cleveland Clinic Health System.

From 6/10/20 to 10/28/21, 13 patients were managed on VA ECMO for COVID-19 disease. Nine patients were identified to have FM based on the clinical features, laboratory analyses and imaging findings. Average age of these patient was 40 years. 5 out of the 9 patients had cardiac arrest. The mean duration of VA ECMO support was 6.8 days. 7 out of the 9 patients survived to hospital discharge. The mean total length of stay was 38 days and ICU length of stay was 31 days. In summary, our case series highlights the risk that COVID-19 poses to unvaccinated patients and the severity of FM in COVID-19 disease. We report a favorable survival trend after FM secondary to COVID-19 with VA ECMO support. We also acknowledge that access to this therapy is limited and long-term sequelae of COVID-19 disease and prolonged hospitalization related complications are still underrecognized. 

First case of COVID-19 complicated with fulminant myocarditis: a case report and insights

Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support -a case report

Acute heart failure in the course of fulminant myocarditis requiring mechanical circulatory support in a healthy young patient after coronavirus disease 2019

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry

Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military

Authors would like to acknowledge the entire ECMO team at the Cleveland Clinic for providing outstanding clinical care for patients with this life-threatening condition.